In Committee from the Senate of Canada - Social Affairs, Science and Technology - February 27, 2013
Social Affairs, Science and Technology
The committee begins phase three of its study on prescription pharmaceuticals in Canada.
Dr. Jeff Poston from the Canadian Pharmacists Association, Dr. Kara Laing of the Canadian Association of Medical Oncologists and Dr. Jitender Sareen from the Canadian Psychiatric Association discuss off-label use of prescription drugs. Off-label use is a term used to describe the prescription of a drug for a purpose other than its purpose according to the licence it received.